Terns Pharmaceuticals
TERN
TERN
112 hedge funds and large institutions have $415M invested in Terns Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
+9
Holders Change %
+8.74%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
27
Increased
36
Reduced
34
Closed
17
Calls
$1.16M
Puts
$362K
Net Calls
+$794K
Net Calls Change
-$539K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$19.5M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$14.6M |
| 3 |
Millennium Management
New York
|
$22.5M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
$7.84M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
$4.1M |
Top Sellers
| 1 |
SCM
Suvretta Capital Management
New York
|
$8.95M |
| 2 |
Morgan Stanley
New York
|
$3.85M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
$0 |
| 4 |
VA
VR Adviser
New York
|
$22.4M |
| 5 |
PA
Perceptive Advisors
New York
|
$0 |
